Ignite Creation Date:
2024-05-05 @ 10:03 PM
Last Modification Date:
2024-10-26 @ 10:12 AM
Study NCT ID:
NCT01010620
Status:
COMPLETED
Last Update Posted:
2019-08-19
First Post:
2009-07-08
Brief Title:
Screening Protocol for Research Participants
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Study Overview
Official Title:
Screening Protocol for the Evaluation of Research Participants
Status:
COMPLETED
Status Verified Date:
2019-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ScreenProt
Brief Summary:
The Screening Protocol is a system devised to evaluate potential research participants for National Institute on Drug AbuseMaryland Psychiatric Research Center NIDAMPRC studies
Detailed Description:
The MPRCNIDA collaborative research program attempts to elucidate the nature of serious mental illnesses drug abuse and addiction determine the potential use of new therapies both pharmacological and psychosocial and decipher the long-term effects of drugs of abuse on the development maturation function and structure of the brain and other organ systems In support of this work the scientific goal of this screening protocol is to assess potential research participants eligibility for research studies Screening will include medical and psychological tests and procedures The data collected during screening are a unique and valuable source of information that aids in the research mission Therefore a secondary goal of this protocol is to obtain data that characterizes the population of subjects contacting NIDA about research participation and to analyze data so obtained such as that on the prevalence and consequences of HIVAIDS viral hepatitis and related diseases and issues of selection and sample bias in clinical research
The screening process will be done in two stages a telephone interview and an in-person evaluation The telephone interview will last approximately 20 minutes and be conducted solely via the NIDA call center Answers provided during the phone interview will indicate whether a caller is eligible for in-person screening Those who appear eligible will be given an appointment at either NIDA or MPRC This protocol pertains only to the in-person participants at MPRC Written informed consent will be obtained when the person arrives The screening process can involve up to 5 visits to MPRC
The screening process will be done in two stages a telephone interview and an in-person evaluation The telephone interview will last approximately 20 minutes and be conducted solely via the NIDA call center Answers provided during the phone interview will indicate whether a caller is eligible for in-person screening Those who appear eligible will be given an appointment at either NIDA or MPRC This protocol pertains only to the in-person participants at MPRC Written informed consent will be obtained when the person arrives The screening process can involve up to 5 visits to MPRC
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| MPRC 412 | None | None | None |
| NIDA 444 | None | None | None |